Eisai Announces FDA Accepts NDA for Once-Daily Formulation of Antiobesity Agent Belviq

Eisai Co., Ltd. (OTC: ESALY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug ...